The Clinical Trials Unit, created in 2014, is an essential component of the Champalimaud Clinical Centre in terms of clinical research, which supports organising, performing and monitoring clinical studies involving patients, in both observational and interventional trials.

Whenever possible and clinically relevant, patients are given the opportunity to participate in clinical trials. These types of studies are implemented in order to make progress in this area and find the best treatments and paradigms.

In parallel with clinical trials of new drugs, funded by the pharmaceutical companies that promote the drugs to be tested, clinical research projects are developed in the areas of diagnostic imaging (especially those based on magnetic resonance); high-precision radiotherapy; radiopharmacology; the study of the mechanisms of metastasis progression, and multispectral microscopy analysis. All this is done in close collaboration with groups dedicated to the most fundamental areas of oncobiology, genomics and computational biology in other national and international centres.

The area of activity of the Unit covers all the pathologies treated at the Champalimaud Clinical Centre, giving patients the possibility to actively participate in the scientific development of new treatments against cancer and to benefit from innovative therapeutic strategies that can lead to better clinical results.